1-3 of 3
Ken-ichi Inui
Close
Sort by
Journal Articles

Anti-Tumor Effect of INNO-406, a Novel Bcr-Abl Inhibitor in Combination with Cyclosporin A Against the Murine Central Nervous System and Systemic Leukemia Model.

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa
Journal: Blood
Blood (2007) 110 (11): 1598.
https://doi.org/10.1182/blood.V110.11.1598.1598
Published: 2007
Journal Articles

Cyclosporin A, a P-gp Inhibitor, Augments the Anti-Central Nervous System Ph + Leukemia Effects of INNO-406.

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa
Journal: Blood
Blood (2006) 108 (11): 834.
https://doi.org/10.1182/blood.V108.11.834.834
Published: 2006
Journal Articles

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph + leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Junya Kuroda, Kiyoshi Sato, Yuri Kamitsuji, Eri Kawata, Yasuyuki Deguchi, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa
Journal: Blood
Blood (2006) 109 (1): 306–314.
https://doi.org/10.1182/blood-2006-03-013250
Published: 2006
Includes: Supplemental data